奮達科技(002681.SZ):擬以5.02億元將富誠達100%股權轉讓給麥滔科技
格隆匯12月28日丨奮達科技(002681.SZ)公佈,公司擬將持有的全資子公司深圳市富誠達科技有限公司(“富誠達”)100%股權以總價5.02億元的價格轉讓給山東麥滔科技有限公司(“麥滔科技”),本次交易尚具有不確定性,請廣大投資者注意投資風險。
公司於2021年12月28日召開第四屆董事會第二十五次會議(臨時),會議審議通過了《關於轉讓全資子公司100%股權的議案》,決定將持有的全資子公司富誠達100%股權轉讓給麥滔科技,麥滔科技與公司簽訂了《關於收購深圳市富誠達科技有限公司100%股權之股權轉讓協議》。本次交易完成後,公司將不再持有富誠達的股權,富誠達不再納入公司合併報表範圍核算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.